Commentary Questions Radiology's Role in WHO 2022 Renal Cell Tumor Update

The WHO 2022 renal cell tumor classification adds histologic complexity; an invited commentary asks whether the new subtypes have practical, actionable translation for routine radiologic reporting.

• Opinion piece reflecting on the radiology applicability of the 2022 WHO renal cell tumor updates, not a primary study.
• Highlights that increased diagnostic precision through molecular/histologic subtyping may not yet yield direct imaging correlates or reporting changes.
• No quantitative data; the commentary frames the gap between pathologic detail and current imaging capabilities.

RadPigeon summaries are original and for information only. They are not clinical advice.